This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders USA
RNA breakthroughs, Case Studies and Partnerships
September 10-11, 2025Boston Exhibition & Convention Center, USA
Book Now
Menu
Book

Garth Kinberger
SVP of Chemistry at Atalanta Therapeutics
Speaker

Agenda Sessions

  • Preclinical study of durable suppression of seizures in a mouse model of KCNT1 epilepsy with divalent small interfering RNA”

    , 2:55pm
    View Session

At this event

Prev
Next
Tasuku Kitada
President and Head of R&D
Strand Therapeutics

See Garth at RNA Leaders USA

Book Now